药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sertaconazole
Obinutuzumab
The risk or severity of bleeding and hemorrhage can be increased when Rivaroxaban is combined with Obinutuzumab.
Sertaconazole
Ibrutinib
The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Rivaroxaban.
Sertaconazole
Edoxaban
The risk or severity of bleeding can be increased when Edoxaban is combined with Rivaroxaban.
Sertaconazole
Hyodeoxycholic Acid
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Hyodeoxycholic Acid.
Sertaconazole
Dehydrocholic acid
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Dehydrocholic acid.
Sertaconazole
Bamet-UD2
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Bamet-UD2.
Sertaconazole
Tauroursodeoxycholic acid
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Tauroursodeoxycholic acid.
Sertaconazole
Taurochenodeoxycholic acid
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Taurochenodeoxycholic acid.
Sertaconazole
Chenodeoxycholic acid
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Chenodeoxycholic acid.
Sertaconazole
Deferasirox
The risk or severity of gastrointestinal bleeding can be increased when Rivaroxaban is combined with Deferasirox.
Sertaconazole
Dabigatran etexilate
Dabigatran etexilate may increase the anticoagulant activities of Rivaroxaban.
Sertaconazole
Apixaban
Apixaban may increase the anticoagulant activities of Rivaroxaban.
Candicidin
Technetium Tc-99m oxidronate
Ferumoxytol can cause a decrease in the absorption of Technetium Tc-99m oxidronate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Phosphate ion
Ferumoxytol can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Calcium phosphate dihydrate
Ferumoxytol can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Ferric pyrophosphate citrate
Ferumoxytol can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Sodium tripolyphosphate
Ferumoxytol can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Calcium Phosphate
Ferumoxytol can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Sodium phosphate, monobasic
Ferumoxytol can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candicidin
Dipotassium phosphate
Ferumoxytol can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.